MedTrace Logo

Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry

NCT02261623 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 415

Last updated 2020-01-06

No results posted yet for this study

Summary

The purpose of this study is to document stent functionality and practice patterns in Canada pertaining to indications for use and stent type selection for self-expanding biliary metal stents (SEMS) when used per standard of practice.

Conditions

  • Biliary Strictures

Interventions

DEVICE

WallFlex™ Biliary RX Fully Covered Stent System RMV

For use in the palliative treatment of biliary strictures produced by malignant neoplasms, and for treatment of benign biliary strictures

DEVICE

WallFlex™ Biliary RX Partially Covered Stent System

For use in the palliative treatment of biliary strictures produced by malignant neoplasms.

DEVICE

WallFlex™ Biliary RX Uncovered Stent System

For use in the palliative treatment of biliary strictures produced by malignant neoplasms.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Gurpal Sandha, MD · University of Alberta

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-19
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02261623 on ClinicalTrials.gov